Analytical and Clinical Performance of VIDAS® HIV DUO AG/AB Assay for Enhanced Early HIV Diagnosis
Véronique Lemée, Mathilde Lacôte, Peggy Nomade, Yves Mérieux, Sandrine Gréaume, Isabelle Voisin, Laurence Bridon, Jean-Christophe Plantier, Elodie Alessandri-Gradt, Vinca Icard · 2026
Read Analytical and Clinical Performance of VIDAS® HIV DUO AG/AB Assay for Enhanced Early HIV Diagnosis by Véronique Lemée, Mathilde Lacôte, Peggy Nomade, Yves Mérieux, Sandrine Gréaume, Isabelle Voisin, Laurence Bridon, Jean-Christophe Plantier, Elodie Alessandri-Gradt, Vinca Icard (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13605314.txt.
Description
Véronique Lemée and co-authors present a study dated 2026 on a test for early HIV diagnosis. Fourth-generation tests detect both a viral protein and antibodies, catching infections before the body has fully responded. The team checked a new assay, the VIDAS HIV DUO AG/AB, in a multicenter evaluation.
Test panels included world health standards, virus cultures of many types, and thousands of patient samples. The new assay found the viral protein at lower levels than the older version it was compared with. It caught infection earlier in over thirty percent of conversion panels, gaining sixty days in total. Samples came from over six thousand HIV-negative and hundreds of HIV-positive people. Precision checks followed standard lab guidelines.
Catalog record
| CREATOR | Véronique Lemée, Mathilde Lacôte, Peggy Nomade, Yves Mérieux, Sandrine Gréaume, Isabelle Voisin, Laurence Bridon, Jean-Christophe Plantier, Elodie Alessandri-Gradt, Vinca Icard |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |